跳至主要内容
临床试验/ISRCTN30371072
ISRCTN30371072已完成不适用

Effects of Mediterranean-style diet on inflammation markers and reversion of metabolic syndrome in cancer patients: role of plasmatic calprotectin

ational Cancer Institute G. Pascale Foundation0 个研究点目标入组 150 人开始时间: 2015年10月19日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged between 18 and 65 years
  • 2. Oncology patients
  • 3. Have at least three of the following characteristics:
  • 3.1. Waist circumference of at least 88 cm in women and 102 cm in men
  • 3.2. Low levels of serum high density lipoprotein cholesterol (HDL), specifically less than 40 mg/dL for men and less than 50 mg/dL for women (or taking drug treatment for reduced HDL-C)
  • 3.3. Hypertriglyceridemia with triglycerides level of at least 150 mg/dL (or taking drug treatment for elevated triglycerides is an alternate indicator)
  • 3.4. Systolic blood pressure of at least 130 mmHg and diastolic blood pressure of at least 85 mmHg (or taking antihypertensive drug treatment in a patient with a history of hypertension)
  • 3.5. Fasting plasma glucose value of 100 mg/dL or greater due to loss of glucose homeostasis (or taking drug treatment of elevated glucose is an alternate indicator)

排除标准

  • 1. Patients with cognitive and psychosocial problems
  • 2. Genetic disorders
  • 3. Smokers
  • 4. Drug addicts or abusers of alcohol (consumption of at least =500 g/wk in the last year)

研究者

发起方
ational Cancer Institute G. Pascale Foundation

相似试验